Anthony Germinaro Joins PetVivo Holdings as Business Manager
Anthony Germinaro Joins PetVivo Holdings, Inc. as Field Veterinary Business Development Manager
PetVivo Holdings, Inc. (OTCB: PETV & PETVW), an emerging biomedical device company dedicated to developing innovative medical devices and therapeutics for companion animals and animal athletes, proudly announces the appointment of Anthony Germinaro as its new Field Veterinary Business Development Manager for the Southwest Region of the United States.
Comments from Leadership
John Lai, Chief Executive Officer of PetVivo Holdings, Inc., expressed enthusiasm regarding the addition of Germinaro to the sales and distribution team. “Adding Anthony to our team provides a tremendous boost to PetVivo’s commercialization efforts,” said Lai. “Anthony brings a wealth of veterinary clinic experience, which is invaluable in raising awareness of our innovative product Spryng with OsteoCushion technology among veterinarians in the Southwest Region.”
About Anthony Germinaro
With over 14 years of experience in the animal health industry, Anthony Germinaro has cultivated significant expertise in veterinary clinics as well as in sales of animal health products. His professional journey includes roles such as lead ultrasound technician and practice manager, obtaining experience in sales and veterinary clinic management at notable establishments including Dr. Fossum’s Pet Care, Anivive Life Sciences, Black Mountain Veterinary Cardiology, Banfield Pet Hospital, and VetMed.
Anthony's Vision
In his own words, Anthony Germinaro remarked, “Joining PetVivo as a Field Veterinary Business Development Manager is an incredible opportunity for me to continue my passion, utilize my industry knowledge, and enhance the quality of life for horses and companion animals. I am thrilled to be part of a company that provides technology proven to improve medical outcomes for animals dealing with lameness and joint-related conditions, such as osteoarthritis.”
About PetVivo Holdings
PetVivo Holdings, Inc. (OTCQB: PETV, PETVW) focuses on manufacturing, commercialization, and licensing cutting-edge medical devices and therapeutics for companion animals. The company aims to develop human therapies in a capital-efficient manner while accelerating timelines to market entry for veterinary medical devices, which facilitates quicker revenues when compared to more heavily regulated human pharmaceuticals and biologics.
Product Innovations
PetVivo has established a strong product pipeline aimed at both animal and human medical treatments. With a portfolio of 21 patents covering the company’s biomaterials, products, and methods of use, they have launched their flagship product, Spryng with OsteoCushion Technology. This veterinarian-administered, intra-articular injectable product is tailored for managing lameness and related joint ailments, including osteoarthritis, in cats, dogs, and horses.
Company Disclosure Information
PetVivo uses its Investor Relations website for disclosing material nonpublic information and fulfilling its obligations under Regulation FD. Investors are encouraged to regularly check the Investor Relations site and engage with the company’s press releases, SEC filings, public conference calls, presentations, and webcasts for updates.
Contact Information
Company Contact:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
Tel: (952) 405-6216
Investor Contact:
Ronald Both or Grant Stude
CMA Investor Relations
Tel: (949) 432-7566
Email: investor@petvivo.com
Frequently Asked Questions
1. Who is Anthony Germinaro?
Anthony Germinaro is the newly appointed Field Veterinary Business Development Manager for PetVivo Holdings, bringing over 14 years of experience in the animal health industry.
2. What role will Germinaro have at PetVivo?
He will focus on enhancing the company’s commercialization efforts in the Southwest Region of the United States, raising awareness for innovative products like Spryng with OsteoCushion technology.
3. What is Spryng with OsteoCushion Technology?
Spryng is an intra-articular injectable product designed for veterinarians to treat lameness and joint-related issues, including osteoarthritis, in companion animals.
4. What is the mission of PetVivo Holdings?
PetVivo focuses on developing and commercializing veterinary medical devices and therapeutics to improve the health and well-being of companion animals.
5. How can I contact PetVivo Holdings?
You can contact PetVivo Holdings through their CEO, John Lai, at the email info1@petvivo.com or call (952) 405-6216 for inquiries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/